Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$24,193,000
-$249,000 QoQ
Shares Held
260,000
-5.5% QoQ
Ownership
0.104%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#40
of 283 holders
Holding Since
Mar 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Hudson Bay Capital Management LP holds $565,820,903 across 77 Biotechnology names. BNTX ranks #4 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
390,440 | $193,943,261 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
825,002 | $47,206,614 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
148,720 | $44,769,181 | |
| 4 | BNTX |
BioNTech SE
This page
|
260,000 | $24,193,000 | |
| 5 | IMCR |
Immunocore Holdings plc
|
590,000 | $18,732,500 | |
| 6 | TECH |
BIO-TECHNE Corp
|
200,000 | $14,130,000 | |
| 7 | VIR |
Vir Biotechnology, Inc.
|
1,364,000 | $13,899,160 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
159,778 | $13,033,091 |
All Filings in BNTX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,193,000 | 260,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $24,442,000 | 275,000 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $35,700,000 | 375,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $20,217,494 | 205,004 | Shares | Sole | 2025-12-15 | |
| 2025-06-30 | $15,970,500 | 150,000 | Shares | Sole | 2025-08-18 | |
| 2025-03-31 | $15,024,900 | 165,000 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $14,813,500 | 130,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $15,440,100 | 130,000 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $27,852,776 | 346,600 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $15,682,500 | 170,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $9,498,600 | 90,000 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $5,975,200 | 55,000 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,634,400 | 80,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,982,800 | 40,000 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $1,348,800 | 10,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,118,250 | 7,500 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $3,837,600 | 22,500 | Shares | Sole | 2022-05-16 | |
| 2020-03-31 | $1,168,000 | 20,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||